Nuvilex Growing Medical Marijuana Sciences to Lead Marijuana Research Industry
January 09, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 9, 2014) - There aren't too many biotechnology companies in the marijuana space, but there's one that aims to be the leader among those in the industry. Nuvilex,...
Nuvilex's Medical Marijuana Sciences Ready to Welcome New York State's Approval of the Drug
January 07, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 7, 2014) - This week executives at Nuvilex, Inc. (OTCQB: NVLX) expect New York state to join 20 other states and the District of Columbia in allowing the use of...
Nuvilex's Medical Marijuana Subsidiary Poised for Growth in the New Year
January 03, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 3, 2014) - Nuvilex, Inc. (OTCQB: NVLX) will be starting 2014 off with a flurry of activity inside its wholly owned subsidiary, Medical Marijuana Sciences, Inc....
Nuvilex Lands Leading Figure in Medical Marijuana Field as Chairman of Subsidiary's Scientific Advisory Board
December 23, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Dec 23, 2013) - Nuvilex, Inc. (OTCQB: NVLX) upped the ante this month in the field of medical marijuana when it appointed Dr. Mark L. Rabe as Chairman of its...
Nuvilex's Medical Marijuana Research Could Use Cell Encapsulation Technology to Address Brain Cancers
December 18, 2013 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Dec 18, 2013) - The executives at Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary, Medical Marijuana Sciences, Inc., had to take note of recent results released in a...
Nuvilex to Answer Increasing Calls for Better Pancreatic Cancer Treatment Without Gemcitabine
December 16, 2013 09:15 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Dec 16, 2013) - Nuvilex, Inc. (OTCQB: NVLX) may be just what the National Cancer Institute (NCI) and a growing number of doctors ordered - the company's late stage...
After Pancreatic Cancer, Eli Lilly and Nuvilex Could Battle Over Diabetes Treatment
December 05, 2013 09:15 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Dec 5, 2013) - Eli Lilly & Co. (LLY) has parlayed its cancer drug Gemzar® or gemcitabine into well over $10 billion since it gained approval to treat advanced,...
Nuvilex Ahead of the Curve on Cannabidiol as FDA Issues Landmark Approval
November 29, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 29, 2013) - A new FDA approval has created a buzz inside biotechs involved with medical marijuana research. When Nuvilex, Inc. (OTCQB: NVLX) announced the...
Nuvilex's Acquisition of Diabetes Rights Should Put the Company on Everyone's Radar
November 19, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Nuvilex, Inc. (OTCQB: NVLX) recently acquired the exclusive worldwide rights to a proprietary cellulose-based live-cell encapsulation technology for...
Investors Confidently Back Nuvilex's Acquisition of Diabetes Technology
November 12, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 12, 2013) - Nuvilex, Inc. (OTCQB: NVLX) announced last week that it has acquired the exclusive worldwide rights to a cellulose-based live-cell encapsulation...